AzTrials
AzTrials

Cubital Tunnel SyndromeNCT07862543

Comparing Surgical and Nonsurgical Outcomes of Cubital Tunnel Syndrome

A study testing Cubital tunnel release and Conservative Arm in people with Cubital Tunnel Syndrome, run by University of Pittsburgh at 7 sites in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

Cubital tunnel syndrome is a condition that occurs when the ulnar nerve, which runs along the inside of the elbow, becomes irritated or compressed. It can cause pain, numbness, tingling, or weakness in the hand and arm. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cubital Tunnel Syndrome
What is being tested?
Cubital tunnel release and Conservative Arm
Could I receive a placebo?
No, everyone receives an active treatment
How many people
220 participants
Where
7 sitesUnited States
Study dates
Oct 2026to Jul 2030
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older
  • Mild-to-moderate severity based on McGowan and Dellon classification:
  • Mild: Purely sensory symptoms without motor deficit or intrinsic atrophy
  • Moderate: Sensory symptoms with mild motor weakness (grip or pinch) without fixed clawing or significant intrinsic wasting
  • Symptom duration of at least 6 weeks
  • Willing and able to comply with follow-up schedule, study procedures, and splinting protocol if randomized to conservative management
  • Able to provide written informed consent

Who cannot join

  • Severe cubital tunnel syndrome by McGowan and Dellon classification (fixed intrinsic weakness, significant muscle wasting, or complete sensory loss)
  • Prior ulnar nerve surgery at the elbow on the affected side
  • Concomitant peripheral neuropathy (e.g., diabetic neuropathy, Charcot-Marie-Tooth disease) that may confound electrodiagnostic or clinical assessment
  • Active elbow fracture, dislocation, or other acute traumatic injury to the affected extremity
  • Known space-occupying lesion at the cubital tunnel (e.g., ganglion cyst, lipoma, bony spur) identified on prior imaging
  • Inflammatory arthropathy affecting the elbow (e.g., rheumatoid arthritis)
Show all 9Show fewer
  • Pregnancy
  • Inability to comply with follow-up visits or complete patient-reported outcome instruments
  • Concurrent participation in another interventional study affecting upper extremity function

Trial locations and contacts

7 sites in 1 country. Contact the study team or a site near you to ask about taking part.

John R Fowler, MD contact

412-605-3245

fowlerjr@upmc.edu

Michael P Chen, MD contact

4258919823

chenmp@upmc.edu

7 sites in 1 country

United States7 sites
  • UPMC Bethel Park

    Bethel Park, Pennsylvania, 15102

    Michael P Chen, MD, 4258919823, chenmp@upmc.edu

  • UPMC Lemieux Sports Complex

    Cranberry Township, Pennsylvania, 16066

    Michael P Chen, 39, 4258919823, chenmp@upmc.edu

  • UPMC Passavant

    Cranberry Township, Pennsylvania, 16066

    Michael P Chen, MD, 4258919823, chenmp@upmc.edu

  • UPMC East

    Monroeville, Pennsylvania, 15146

    Michael P Chen, MD, 4258919823, chenmp@upmc.edu

  • UPMC Montefiore

    Pittsburgh, Pennsylvania, 15213

    Michael P Chen, MD, 4258919823, chenmp@upmc.edu

  • UPMC

    Pittsburgh, Pennsylvania, 15213

    Michael P Chen, MD, 4258919823, chenmp@upmc.edu

  • UPMC Mercy

    Pittsburgh, Pennsylvania, 15219

Other trials in United States

About this study

Official title: Nonoperative vs. Surgical Decompression for Mild-to-Moderate Cubital Tunnel Syndrome: A Prospective Randomized Controlled Trial

Cubital tunnel syndrome is a condition that occurs when the ulnar nerve, which runs along the inside of the elbow, becomes irritated or compressed. It can cause pain, numbness, tingling, or weakness in the hand and arm. The goal of this clinical trial is to investigate whether early surgery leads to better outcomes than a non-surgical treatment approach using an elbow night splint for mild-to-moderate cubital tunnel syndrome in adults.

This study aims to answer the following questions:

Read more
  • Does earlier surgical intervention improve patient-reported pain, symptoms, and function more than treatment with an elbow night splint after one year?
  • How do symptoms, function, nerve function, and ultrasound findings compare between the two treatments over two years?
  • How often do people who initially receive treatment with an elbow night splint end up needing surgery?
  • Researchers will compare early surgery with treatment using an elbow night splint to see how the two approaches affect symptoms and function.

Participants will...

  • be randomly assigned to have surgery or to receive treatment with an elbow night splint.
  • have a physical examination at each study visit.
  • have tests of nerve function and ultrasound imaging of the elbow.
  • answer questionnaires about their symptoms, pain, and arm and hand function.
  • attend appointments at the start of the study, and at 6 weeks, 3 months, 6 months, 1 year, and 2 years.
Read the detailed description

Background and Rationale Cubital tunnel syndrome (CuTS) is the second most common peripheral nerve compression syndrome of the upper extremity after carpal tunnel syndrome. It results from compression or traction of the ulnar nerve at the elbow, most commonly at the cubital tunnel retinaculum or the aponeurosis of the flexor carpi ulnaris. Clinical manifestations include paresthesias and numbness in the ring and small fingers, intrinsic hand weakness, and pain along the medial elbow.

Current management strategies range from conservative measures, such as activity modification and elbow bracing, to surgical intervention, including in-situ decompression and ulnar nerve transposition. For mild-to-moderate disease, the current standard of care is an initial trial of conservative management with elbow night splinting, with surgical intervention reserved for patients who do not improve or whose symptoms progress. However, the comparative effectiveness of this staged approach versus early surgical intervention has not been rigorously evaluated in a prospective, randomized trial. Additionally, objective measures of ulnar nerve structure and function have not been systematically correlated with clinical and patient-reported outcomes across treatment approaches.

Study Objective This study aims to address this gap by prospectively comparing initial conservative management with early surgical intervention for mild-to-moderate cubital tunnel syndrome. Participants will be followed for two years to evaluate clinical, functional, imaging, electrodiagnostic, and patient-reported outcomes and to assess the frequency and timing of conversion from conservative to surgical management.

Study Design This is a prospective, single-center, randomized controlled trial. Eligible participants will be randomly assigned in a 1:1 ratio to either conservative management with elbow night splinting or early surgical intervention.

Randomization will be performed using a computer-generated block randomization scheme with variable block sizes, stratified by disease severity (mild vs. moderate per Dellon classification). The allocation sequence will be concealed in sequentially numbered, opaque, sealed envelopes opened at the time of enrollment.

Patient Population Adults with mild-to-moderate cubital tunnel syndrome who meet the study eligibility criteria will be considered for enrollment. Participants must be able to provide informed consent and comply with study procedures and follow-up. Patients with severe disease, prior ulnar nerve surgery on the affected side, conditions that could substantially confound assessment of ulnar nerve function, acute traumatic conditions of the affected extremity, or other protocol-defined exclusion criteria will not be eligible.

Being tested
Cubital tunnel release, Conservative Arm
Keywords
cubital tunnel, randomized trial
Medical subject headings
Cubital Tunnel Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cubital tunnel releaseProcedure or surgery

    Also called ulnar nerve decompression

    This surgical intervention occurs without other prior conservative intervention.

  • Conservative ArmProcedure or surgery

    Also called night splinting, activity modification, anti-inflammatory medications, physical therapy

    Conservative management with the option to convert to surgical intervention if conservative measures fail

Study groups in NCT07862543
Study groupRoleWhat they receive
ConservativeActive comparatorConservative management of cubital tunnel syndrome with option to convert to surgical management
Receives: Procedure: Conservative Arm
SurgicalExperimentalSurgical management of cubital tunnel syndrome
Receives: Procedure: Cubital tunnel release

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Patient-Rated Ulnar Nerve Evaluation (PRUNE) Score from baseline to 1 year

    0 indicates no symptoms or functional deficits; 100 indicates worst possible symptoms and functional deficits; "change" refers to differences between each timepoint and the baseline, as well as the differences between each consecutive timepoint

    Measured: Baseline, 6 weeks, 3 months, 6 months, 1 year

Secondary outcomes (18)
  1. Change in Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) at Each Timepoint; "change" refers to differences between each timepoint and the baseline, as well as the differences between each consecutive timepoint

    0 indicates no disability; 100 indicates the most severe disability; "change" refers to differences between each timepoint and the baseline, as well as the differences between each consecutive timepoint

    Measured: Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years

  2. Grip strength

    Change in grip strength measured with a Jamar dynamometer

    Measured: Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years

  3. Pinch strength

    Change in lateral, tip, and palmar pinch strength.

    Measured: Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years

  4. Two-point discrimination

    Change in static and moving sensory discrimination in the ulnar nerve distribution.

    Measured: Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years

  5. Semmes-Weinstein monofilament threshold

    Change in sensory threshold in the ulnar nerve distribution.

    Measured: Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years

  6. Ulnar nerve cross-sectional area

    Change in ultrasound-measured ulnar nerve size at the cubital tunnel.

    Measured: Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years

  7. Ulnar nerve conduction velocity

    Change in sensory and motor conduction velocity across the elbow.

    Measured: Baseline and 1 year

  8. Electrodiagnostic severity grade

    Change in overall electrodiagnostic severity classified as normal, mild, moderate, or severe.

    Measured: Baseline and 1 year

  9. McGowan/Dellon grade

    Change in clinical severity classification of cubital tunnel syndrome.

    Measured: Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years

  10. Rate of Surgical Conversion

    Proportion of participants in the conservative arm who proceed to surgical treatment.

    Measured: From initiation of conservative treatment through 6 months of treatment

  11. Time to conversion

    Time from initiation of conservative treatment to surgical conversion

    Measured: From initiation of conservative treatment through 6 months of treatment

  12. Patient satisfaction

    Participant-reported satisfaction with treatment outcome using a 5-point Likert scale (minimum 1; maximum 5; higher score indicates greater satisfaction)

    Measured: Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years

  13. Global Rating of Change

    Participant-reported overall change in symptoms and function (minimum -3 indicating much worse; maximum +3 indicating much better)

    Measured: Baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years

  14. Return to work

    Time required to return to work following surgical treatment.

    Measured: From surgery until return to work or two years after enrollment, whichever comes first

  15. Return to full activity

    Time required to resume full activity following surgical treatment

    Measured: From surgery until return to full activity or two years after enrollment, whichever comes first

  16. Complication rate

    Occurrence of treatment-related complications

    Measured: From treatment initiation through 2 years after enrollment

  17. Reoperation rate

    Occurrence of revision or repeat surgical treatment

    Measured: From initial surgery through 2 years after enrollment

  18. PRUNE clinically meaningful improvement

    Change in PRUNE score corresponding to meaningful patient-reported improvement, determined using patient satisfaction and Global Rating of Change at 1 year as anchors. Patients reporting "satisfied" or "very satisfied" and/or positive change will be considered meaningfully improved, and ROC analysis will be used to identify the PRUNE change threshold that best distinguishes meaningful improvement from non-meaningful improvement.

    Measured: From enrollment to 1 year after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Oct 2026
  2. Study startOct 2026 (estimated)
  3. Primary completionJul 2028 (estimated)
  4. Study completionJul 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
220 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07862543
Sponsor's protocol ID
STUDY26060110
Status last verified
Oct 2026
First submitted
8 Sep 2026
Last updated
20 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared with outside researchers to preserve participant privacy and confidentiality.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in